4//SEC Filing
Katkin Keith 4
Accession 0000950170-25-004922
CIK 0001404281other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 5:30 PM ET
Size
7.8 KB
Accession
0000950170-25-004922
Insider Transaction Report
Form 4
Katkin Keith
Director
Transactions
- Award
Restricted Stock Units
2025-01-10+8,575→ 8,575 total→ Common Stock (8,575 underlying) - Award
Stock Option (right to buy)
2025-01-10+77,175→ 77,175 totalExercise: $4.04Exp: 2035-01-10→ Common Stock (77,175 underlying)
Footnotes (3)
- [F1]This option represents a right to purchase up to 77,175 shares of common stock, which option vests with respect to 100% of the total number of shares on January 10, 2026.
- [F2]Each restricted stock unit represents a contingent right to receive 1 share of the Issuer's common stock upon settlement for no consideration.
- [F3]100% of the restricted stock units will vest on January 10, 2026.
Documents
Issuer
Eledon Pharmaceuticals, Inc.
CIK 0001404281
Entity typeother
Related Parties
1- filerCIK 0001314596
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 5:30 PM ET
- Size
- 7.8 KB